At Suzhou Dialogue 2019 held by China Pharmaceutical Packaging Association (CNPPA) in Suzhou, SGD Pharma R&D Director Jingwei Zhang will present and deliver a speech at Forum of Technology and Regulation on September 2nd. His sharing will explore the performance and application of container made by tubular glass and molded glass.
Mit Vorarbeit zum Erfolg
Von Stefan Weinzierl
Wenn neue Instandhaltungssoftware läuft, erleichtert sie die Arbeit immens. Damit das klappt, muss zuvor viel Gehirnschmalz investiert werden. Diese Erfahrung machten auch Projektmanager Kevin Fiedler und sein Team bei SGD Pharma Kipfenberg.
More than 9000 tonnes of moulded Type I pharmaceutical glass containers and 4000 tonnes of tubular vials and ampoules (corresponding to more than 700 million pieces) are produced annually at the Vemula (India) glassworks of SGD Pharma. Sardar Akshay Singh, Managing Director of SGD Pharma India, spoke to Glass Worldwide (preferred international AIGMF journal) about the fully integrated facility’s extensive capabilities, prospects and opportunities.
Frederic joined SGD Pharma in 1999. He held various positions in the sales team of North America (New York), Europe (Paris), Asia (Guangzhou) and India (Hyderabad-Vemula).
In 2013, he was part of the team managing the integration of Cogent Glass (now SGD Pharma India) as General Manager of the entity. Once the commercial and technical ramp-ups of SGD Pharma India were on the right track and with a strong team in place led by Akshay Singh, he returned to SGD Asia Pacific as General Manager.
